Marshall Wace’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Buy |
111,200
+71,558
| +181% | +$123K | ﹤0.01% | 2321 |
|
|
2025
Q1 | $132K | Sell |
39,642
-1,090,813
| -96% | -$3.63M | ﹤0.01% | 2335 |
|
|
2024
Q4 | $8.37M | Buy |
+1,130,455
| New | +$8.37M | 0.01% | 791 |
|
|
2024
Q3 | – | Sell |
-1,612,055
| Closed | -$12.9M | – | 2518 |
|
|
2024
Q2 | $12.9M | Buy |
+1,612,055
| New | +$12.9M | 0.02% | 567 |
|
|
2023
Q4 | – | Sell |
-35,011
| Closed | -$159K | – | 2044 |
|
|
2023
Q3 | $159K | Buy |
+35,011
| New | +$159K | ﹤0.01% | 1694 |
|
|
2023
Q1 | – | Sell |
-369,463
| Closed | -$2.36M | – | 2354 |
|
|
2022
Q4 | $2.36M | Buy |
+369,463
| New | +$2.36M | 0.01% | 1296 |
|
|
2022
Q2 | – | Sell |
-50,953
| Closed | -$848K | – | 2929 |
|
|
2022
Q1 | $848K | Sell |
50,953
-810,207
| -94% | -$13.5M | ﹤0.01% | 1905 |
|
|
2021
Q4 | $16.4M | Buy |
+861,160
| New | +$16.4M | 0.03% | 527 |
|
|
2021
Q3 | – | Sell |
-17,867
| Closed | -$465K | – | 2604 |
|
|
2021
Q2 | $465K | Sell |
17,867
-23,932
| -57% | -$623K | ﹤0.01% | 1693 |
|
|
2021
Q1 | $1.32M | Buy |
+41,799
| New | +$1.32M | 0.01% | 1288 |
|
|
2020
Q4 | – | Sell |
-58,026
| Closed | -$1.91M | – | 1883 |
|
|
2020
Q3 | $1.91M | Buy |
58,026
+30,635
| +112% | +$1.01M | 0.01% | 789 |
|
|
2020
Q2 | $752K | Buy |
+27,391
| New | +$752K | 0.01% | 1054 |
|
|
2020
Q1 | – | Sell |
-1,949
| Closed | -$54K | – | 1810 |
|
|
2019
Q4 | $54K | Buy |
+1,949
| New | +$54K | ﹤0.01% | 1487 |
|
|
2019
Q2 | – | Sell |
-566,016
| Closed | -$5.38M | – | 1534 |
|
|
2019
Q1 | $5.38M | Buy |
566,016
+80,510
| +17% | +$766K | 0.05% | 451 |
|
|
2018
Q4 | $4.3M | Buy |
+485,506
| New | +$4.3M | 0.04% | 487 |
|
|
2018
Q2 | – | Sell |
-28,991
| Closed | -$490K | – | 759 |
|
|
2018
Q1 | $490K | Buy |
+28,991
| New | +$490K | 0.02% | 367 |
|